| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |